Watertown, MA, United States of America

Hillary A Keenan

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hillary A. Keenan

Introduction

Hillary A. Keenan is a prominent inventor based in Watertown, MA (US). She has made significant contributions to the field of diabetes research, particularly in predicting and treating diabetic complications. With a total of 2 patents, her work has the potential to greatly impact the lives of individuals suffering from diabetes.

Latest Patents

Hillary's latest patents focus on innovative methods for diagnosing and treating diabetic complications. One of her notable patents is titled "Compositions and methods for diagnosing, predicting risk of and/or treating diabetic nephropathy (DN)." Another significant patent is "Compositions and methods for diagnosing, predicting risk of, and/or treating diabetic retinopathy and/or diabetic nephropathy." These inventions aim to enhance the understanding and management of diabetes-related health issues.

Career Highlights

Hillary A. Keenan is affiliated with the Joslin Diabetes Center, Inc., where she conducts her research and develops her innovative solutions. Her work at this esteemed institution underscores her commitment to advancing diabetes care and treatment.

Collaborations

Hillary has collaborated with notable colleagues, including George Liang King and George L. King. These partnerships have likely contributed to the success and development of her innovative patents.

Conclusion

Hillary A. Keenan's contributions to diabetes research through her patents and work at the Joslin Diabetes Center, Inc. highlight her dedication to improving patient outcomes. Her innovative approaches to diagnosing and treating diabetic complications are paving the way for advancements in diabetes care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…